These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2639638)
1. TFX modulates the immunosuppressive effect of cyclophosphamide on antibody production in mice. Paczek L; Gaciong Z; Górski A; Lagodziński Z; Brzezny M Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):415-9. PubMed ID: 2639638 [TBL] [Abstract][Full Text] [Related]
2. Nitrogranulogen-dependent inhibition of antibody synthesis. I. In vitro studies in man. Wasik M; Stepień-Sopniewska B; Kozakiewicz A; Górski A Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):117-20. PubMed ID: 1804040 [TBL] [Abstract][Full Text] [Related]
3. Restoration of cyclophosphamide-suppressed primary immune response in mice by Tołpa Peat Preparation (TPP)--comparison with calf thymus extract. Obmińska-Domoradzka B Acta Pol Pharm; 1993; 50(6):501-6. PubMed ID: 8067263 [TBL] [Abstract][Full Text] [Related]
4. The influence of thymosin (TEX) on antigen-induced primary and secondary antibody responses of mice. Gaciong Z; Paczek L; Kobryń A; Górski A Arch Immunol Ther Exp (Warsz); 1985; 33(2):311-7. PubMed ID: 3909988 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppression with cyclophosphamide: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production. Bohunická E; Koza I; Kuzela S; Krempaský V; Ujházy V Neoplasma; 1972; 19(6):611-20. PubMed ID: 4596308 [No Abstract] [Full Text] [Related]
6. Nitrogranulogen-dependent inhibition of antibody synthesis. II. In vivo studies in mice. Lagodziński Z; Górski A Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):121-5. PubMed ID: 1804041 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of the antibody response after treatment with thymomodulin in mice immunodepressed with cyclophosphamide and in aging mice. Poli G; Secchi C; Bonizzi L; Guttinger M Int J Tissue React; 1986; 8(3):231-8. PubMed ID: 3781762 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen. Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Sueishi K; Nomoto K; Yasui H Scand J Immunol; 2005 Sep; 62(3):271-80. PubMed ID: 16179014 [TBL] [Abstract][Full Text] [Related]
9. The effect of chronic daily cyclophosphamide administration on established antibody responses. Gagnon RF; MacLennan IC Clin Exp Immunol; 1981 Oct; 46(1):178-84. PubMed ID: 7337968 [TBL] [Abstract][Full Text] [Related]
10. The immunostimulating effect of thymus extract (TFX) on the immunosuppressive action of bacterial endotoxin in skin-allografted mice. Turowski G; Kowalski Z; Wójcik R; Kołodziej J Mater Med Pol; 1978; 10(1):17-23. PubMed ID: 347182 [No Abstract] [Full Text] [Related]
11. Suppression of B cell function by methotrexate and trimetrexate. Evidence for inhibition of purine biosynthesis as a major mechanism of action. Rosenthal GJ; Weigand GW; Germolec DR; Blank JA; Luster MI J Immunol; 1988 Jul; 141(2):410-6. PubMed ID: 2968399 [TBL] [Abstract][Full Text] [Related]
13. Didemnin B: an immunosuppressive cyclic peptide that stimulates murine antibody responses in vivo and in vitro. Montgomery DW; Celniker A; Zukoski CF Transplant Proc; 1987 Feb; 19(1 Pt 2):1295-6. PubMed ID: 3274320 [No Abstract] [Full Text] [Related]
14. Stimulation of antibody-synthesis with immunosuppressive drugs in parabionts. Baenkler HW; Scheiffarth F J Med; 1971; 2(3):143-8. PubMed ID: 4944003 [No Abstract] [Full Text] [Related]
15. Brazilein, an important immunosuppressive component from Caesalpinia sappan L. Ye M; Xie WD; Lei F; Meng Z; Zhao YN; Su H; Du LJ Int Immunopharmacol; 2006 Mar; 6(3):426-32. PubMed ID: 16428078 [TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide intensifies the acquisition of allergic contact dermatitis in mice rendered B-cell deficient by heterologous anti-IgM antisera. Maguire HC; Faris L; Weidanz W Immunology; 1979 Jun; 37(2):367-72. PubMed ID: 313902 [TBL] [Abstract][Full Text] [Related]
17. Myeloablative and immunosuppressive properties of treosulfan in mice. Sjöö F; Hassan Z; Abedi-Valugerdi M; Griskevicius L; Nilsson C; Remberger M; Aschan J; Concha H; Gaughan U; Hassan M Exp Hematol; 2006 Jan; 34(1):115-21. PubMed ID: 16413398 [TBL] [Abstract][Full Text] [Related]
18. Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function. Fidler JM; DeJoy SQ; Gibbons JJ J Immunol; 1986 Jul; 137(2):727-32. PubMed ID: 3487580 [TBL] [Abstract][Full Text] [Related]
19. Comparative activity of CP-17,193 and five established immunosuppressives toward the antigens SRBC and EL4. Otterness IG Clin Exp Immunol; 1981 Nov; 46(2):332-9. PubMed ID: 7039885 [TBL] [Abstract][Full Text] [Related]
20. Antibody plaque reduction in vitro and in vivo: a rapid assay for immunosuppressive agents. Gavin J; Waterbury W; Freidman H Transplant Proc; 1969 Mar; 1(1):413-5. PubMed ID: 4944252 [No Abstract] [Full Text] [Related] [Next] [New Search]